Share on StockTwits

Skyline Medical (NASDAQ:SKLN) COO David O. Johnson purchased 14,300 shares of the stock in a transaction dated Wednesday, August 27th. The stock was purchased at an average price of $0.14 per share, with a total value of $2,002.00. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Shares of Skyline Medical (NASDAQ:SKLN) traded up 3.71% during mid-day trading on Friday, hitting $0.1399. The stock had a trading volume of 55,500 shares. Skyline Medical has a 1-year low of $0.106 and a 1-year high of $0.44. The stock’s 50-day moving average is $0.13 and its 200-day moving average is $0.16. The company’s market cap is $31.2 million.

Skyline Medical Inc, formerly BioDrain Medical, Inc, is an early stage medical device company. The Company owns patent rights to its products and will distribute its products to medical facilities where bodily and irrigation fluids produced during surgical procedures must be contained, measured, documented, and disposed.

Receive News & Ratings for Skyline Medical Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Skyline Medical Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.